Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Seal Rock Therapeutics

    Client Virtual Booth

    SEAL ROCK THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Seal Rock Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    500 Yale Ave N Seattle, WA 98109
    Telephone
    Telephone
    786.453.0593
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sealrocktx.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Genfit licenses liver failure drug from Seal Rock in $107M deal
    Genfit licenses liver failure drug from Seal Rock in $107M deal

    https://www.fiercebiotech.com/biotech/genfit-adds-3rd-liver-failure-asset-roster-107m-biobucks-deal-seal-rock

    James Waldron FIERCE BIOTECH
    01 Jun 2023
    Share Share
    Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT
    Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT

    https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-out-licensing-agreement-with-genfit-for-development-of-injectable-formulation-of-srt-015-for-acute-on-chronic-liver-disease-aclf-301839273.html

    PR NEWSWIRE
    31 May 2023
    Share Share
    Seal Rock Therapeutics Announces Presentations at AASLD's The Liver Meeting 2022
    Seal Rock Therapeutics Announces Presentations at AASLD's The Liver Meeting 2022

    https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-upcoming-oral-and-poster-presentations-at-aaslds-the-liver-meeting-2022-301656962.html

    PRNEWSWIRE
    24 Oct 2022
    Share Share
    Seal Rock Announces Completion of Single Ascending DosePh 1 Trial of ASK1SRT-015
    Seal Rock Announces Completion of Single Ascending DosePh 1 Trial of ASK1SRT-015

    https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-completion-of-single-ascending-dose-cohort-in-phase-1-clinical-trial-of-ask1-inhibitor-srt-015-for-nash-301403152.html

    PRNEWSWIRE
    19 Oct 2021
    Share Share
    Seal Rock Announces Initiation of Phase 1 Clinical Trial of SRT-015
    Seal Rock Announces Initiation of Phase 1 Clinical Trial of SRT-015

    https://www.prnewswire.com/news-releases/seal-rock-therapeutics-announces-initiation-of-phase-1-clinical-trial-of-ask1-inhibitor-srt-015-for-nash-301318169.html

    PRNEWSWIRE
    23 Jun 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search